Smith TA - Search Results

1

Modelling the cost-effectiveness of mass screening and treatment for reducing Plasmodium falciparum malaria burden.

Crowell V, Briët OJ, Hardy D, Chitnis N, Maire N, Di Pasquale A, Smith TA. Crowell V, et al. Among authors: smith ta. Malar J. 2013 Jan 3;12:4. doi: 10.1186/1475-2875-12-4. Malar J. 2013. PMID: 23286228 Free PMC article.

2

The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea.

Marfurt J, Müller I, Sie A, Oa O, Reeder JC, Smith TA, Beck HP, Genton B. Marfurt J, et al. Among authors: smith ta. Malar J. 2008 Apr 19;7:61. doi: 10.1186/1475-2875-7-61. Malar J. 2008. PMID: 18423045 Free PMC article.

3

Malaria--a major health problem within an oil palm plantation around Popondetta, Papua New Guinea.

Pluess B, Mueller I, Levi D, King G, Smith TA, Lengeler C. Pluess B, et al. Among authors: smith ta. Malar J. 2009 Apr 8;8:56. doi: 10.1186/1475-2875-8-56. Malar J. 2009. PMID: 19356235 Free PMC article.

4

Simulation of the cost-effectiveness of malaria vaccines.

Tediosi F, Maire N, Penny M, Studer A, Smith TA. Tediosi F, et al. Among authors: smith ta. Malar J. 2009 Jun 8;8:127. doi: 10.1186/1475-2875-8-127. Malar J. 2009. PMID: 19505328 Free PMC article.

5

Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection.

Müller I, Genton B, Rare L, Kiniboro B, Kastens W, Zimmerman P, Kazura J, Alpers M, Smith TA. Müller I, et al. Among authors: smith ta. Malar J. 2009 Jul 14;8:158. doi: 10.1186/1475-2875-8-158. Malar J. 2009. PMID: 19602275 Free PMC article.

6

Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.

Marfurt J, Smith TA, Hastings IM, Müller I, Sie A, Oa O, Baisor M, Reeder JC, Beck HP, Genton B. Marfurt J, et al. Among authors: smith ta. Malar J. 2010 Jan 7;9:8. doi: 10.1186/1475-2875-9-8. Malar J. 2010. PMID: 20053293 Free PMC article.

7

Uses of mosquito-stage transmission-blocking vaccines against Plasmodium falciparum.

Smith TA, Chitnis N, Briët OJ, Tanner M. Smith TA, et al. Trends Parasitol. 2011 May;27(5):190-6. doi: 10.1016/j.pt.2010.12.011. Epub 2011 Feb 1. Trends Parasitol. 2011. PMID: 21277257

8

A research agenda for malaria eradication: modeling.

malERA Consultative Group on Modeling. malERA Consultative Group on Modeling. PLoS Med. 2011 Jan 25;8(1):e1000403. doi: 10.1371/journal.pmed.1000403. PLoS Med. 2011. PMID: 21283605 Free PMC article. Review.

9

Cost-effectiveness of the introduction of a pre-erythrocytic malaria vaccine into the expanded program on immunization in sub-Saharan Africa: analysis of uncertainties using a stochastic individual-based simulation model of Plasmodium falciparum malaria.

Maire N, Shillcutt SD, Walker DG, Tediosi F, Smith TA. Maire N, et al. Among authors: smith ta. Value Health. 2011 Dec;14(8):1028-38. doi: 10.1016/j.jval.2011.06.004. Epub 2011 Aug 15. Value Health. 2011. PMID: 22152171 Free article.

10

Importance of factors determining the effective lifetime of a mass, long-lasting, insecticidal net distribution: a sensitivity analysis.

Briët OJ, Hardy D, Smith TA. Briët OJ, et al. Among authors: smith ta. Malar J. 2012 Jan 13;11:20. doi: 10.1186/1475-2875-11-20. Malar J. 2012. PMID: 22244509 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

615 results

Search Page

Filters